0.97% 0.0263

InspireMD Inc. (NSPR)

InspireMD Inc. (NSPR) 最新ニュース

InspireMD Inc. (NSPR)

InspireMD Inc. (NSPR) 最新ニュース

InspireMD Advances Stroke Prevention with FDA PMA Submission - TipRanks

InspireMD seeks FDA approval for carotid stent system - Investing.com

InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System - StockTitan

InspireMD Announces Submission of Premarket Approval - GlobeNewswire

InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard? Prime Carotid Stent System - Marketscreener.com

InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - Defense World

StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World

StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - MarketBeat

InspireMD (NYSE:NSPR) Receives New Coverage from Analysts at StockNews.com - Defense World

InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - MarketBeat

InspireMD (NYSE:NSPR) Coverage Initiated by Analysts at StockNews.com - MarketBeat

StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - MarketBeat

InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World

Earnings call: InspireMD reports growth and anticipates US launch By Investing.com - Investing.com Canada

Earnings call: InspireMD reports growth and anticipates US launch - Investing.com

Earnings call: InspireMD reports growth and anticipates US launch By Investing.com - Investing.com Australia

InspireMD, Inc. (NASDAQ:NSPR) Q2 2024 Earnings Call Transcript - Insider Monkey

InspireMD, Inc. (NSPR) Q2 2024 Earnings Call Transcript - Seeking Alpha

InspireMD, Inc. (NSPR) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update - StockTitan

InspireMD (NYSE:NSPR) Now Covered by StockNews.com - MarketBeat

NSPRInspireMD, Inc. Latest Stock News & Market Updates - StockTitan

InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment - GlobeNewswire

InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment - StockTitan

InspireMD (NSPR) Set to Announce Quarterly Earnings on Tuesday - Defense World

InspireMD (NSPR) to Release Earnings on Tuesday - MarketBeat

InspireMD to Report Second Quarter 2024 Financial Results - GlobeNewswire

InspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, August 6th - Yahoo Finance

Embolic Prevention Systems Market [Top Players ] Medtronic, Abbott, InspireMD - Economica

Head to Head Comparison: InspireMD (NYSE:NSPR) and Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) - Defense World

InspireMD (NYSE:NSPR) versus Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Head-To-Head Analysis - American Banking and Market News

StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World

InspireMD Announces Distribution Agreement for CGuard(TM) EPS in Poland - Yahoo Lifestyle UK

InspireMD (NYSE:NSPR) Research Coverage Started at StockNews.com - MarketBeat

Analyzing InspireMD (NYSE:NSPR) and Monogram Orthopaedics (NASDAQ:MGRM) - Defense World

New York Stock Exchange Accepts InspireMD's Plan to Regain Compliance - Yahoo Movies UK

InspireMD announces full exercise of Series H warrant tranche - Medical Buyer

InspireMD Secures Funds to Expand Healthcare Innovations - TipRanks

InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million - GlobeNewswire

InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million - StockTitan

InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million - Yahoo Finance

Meihua International Medical Technologies (NASDAQ:MHUA) versus InspireMD (NYSE:NSPR) Critical Contrast - Defense World

InspireMD Announces Pricing of Public Offering of Approximately $14.6 Million - Yahoo Singapore News

Neurovascular Embolic Protection Device Market with Tremendous growth by 2031 – InspireMD, Inc., Boston Scientific ... - TIMC

Quantisnow - Quantisnow

NAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product Development - Quantisnow

InspireMD (NYSE:NSPR) Research Coverage Started at StockNews.com - Defense World

InspireMD Announces Private Placement of Up to $113.6 Million - Quantisnow

InspireMD Unveils Updated Investor Presentation Online - TipRanks

InspireMD Shareholders Elect Directors and Approve Executive Pay By Investing.com - Investing.com

InspireMD (NYSE:NSPR) Receives New Coverage from Analysts at StockNews.com - MarketBeat

Sensus Healthcare (NASDAQ:SRTS) & InspireMD (NYSE:NSPR) Critical Contrast - Defense World

NSPRに似た銘柄